Table 3.
N | Morphology (n) | Ascites (n) | Peritoneal implant (n) | |||||
Solid | Cystic | ++ | + | − | + | − | ||
Primary malignant ovarian tumors | 42 | 23 | 19 | 21 | 14 | 7 | 37 | 5 |
Serous carcinoma | 36 | 21 | 15 | 19 | 11 | 6 | 34 | 2 |
Clear cell carcinoma | 3 | 1 | 2 | 2 | 0 | 1 | 2 | 1 |
Carcinosarcoma | 2 | 1 | 1 | 0 | 2 | 0 | 1 | 1 |
Endometrioid borderline tumor/carcinoma | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 |
Metastasis | 12 | 5 | 7 | 8 | 4 | 0 | 9 | 3 |
Appendiceal cancer | 3 | 1 | 2 | 3 | 0 | 0 | 2 | 1 |
Cervical cancer | 2 | 1 | 1 | 1 | 1 | 0 | 2 | 0 |
Colon cancer | 2 | 1 | 1 | 0 | 2 | 0 | 2 | 0 |
Bile duct cancer | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 |
Gastric cancer | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 |
Kidney cancer | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
Peritoneal mesothelioma | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 |
Malignant lymphoma | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
Ascites+: not beyond the pelvic cavity; Ascites++: beyond the pelvic cavity
MR, magnetic resonance.